Menzel, M., Endris, V., Schwab, C., Kluck, K., Neumann, O., Beck, S., . . . Budczies, J. (2023). Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD). Translational oncology, 35, . https://doi.org/10.1016/j.tranon.2023.101706
Chicago-Zitierstil (17. Ausg.)Menzel, Michael, et al. "Accurate Tumor Purity Determination Is Critical for the Analysis of Homologous Recombination Deficiency (HRD)." Translational Oncology 35 (2023). https://doi.org/10.1016/j.tranon.2023.101706.
MLA-Zitierstil (9. Ausg.)Menzel, Michael, et al. "Accurate Tumor Purity Determination Is Critical for the Analysis of Homologous Recombination Deficiency (HRD)." Translational Oncology, vol. 35, 2023, https://doi.org/10.1016/j.tranon.2023.101706.